Fenofibrate and Simvastatin interaction

Fenofibrate and Simvastatin: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.

Moderate

Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.

What the FDA labels say

From the Fenofibrate label · effective 2026-05-12

Moderate

Risks are increased during co-administration with a statin, in geriatric patients and in patients with renal impairment, or hypothyroidism.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Pemafibrate did not reduce cardiovascular disease morbidity or mortality in a large, randomized, placebo - controlled trial of patients with type 2 diabetes mellitus on background statin therapy [see Clinical Studies (14.4) ].

Warnings and precautionsby drug classView label on DailyMed
Moderate

Steps to Prevent or Reduce the Risk of Myopathy and Rhabdomyolysis Data from observational studies indicate that the risk for rhabdomyolysis is increased when fibrates, including fenofibrates, are co-administered with a statin.

Warnings and precautionsby drug classView label on DailyMed
Moderate

The risk of myopathy and rhabdomyolysis is increased with concomitant use of fibrates with statins.

Drug interactionsby drug classView label on DailyMed
Moderate

Intervention: Consider if the benefit of using fenofibrate concomitantly with statin therapy outweighs the increased risk of myopathy and rhabdomyolysis.

Drug interactionsby drug classView label on DailyMed

From the Simvastatin (ZOCOR) label · effective 2025-03-28

Moderate

Lipid modifying doses (≥1 gram/day) of niacin, fibrates, colchicine, and grapefruit juice may also increase the risk of myopathy and rhabdomyolysis [see Drug Interactions (7.1) ] .

Warnings and precautionsby drug classView label on DailyMed
Moderate

The risk of myopathy and rhabdomyolysis is increased with concomitant use of fibrates with ZOCOR.

Drug interactionsby drug classView label on DailyMed
Moderate

Intervention: Consider if the benefit of using fibrates concomitantly with ZOCOR outweighs the increased risk of myopathy and rhabdomyolysis.

Drug interactionsby drug classView label on DailyMed
Minor

Fibrates (other than Gemfibrozil) Clinical Impact: Fibrates may cause myopathy when given alone.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.